Dr. Cheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Southeast Texas ER & Hospital
19211 McKay Dr
Humble, TX 77338Phone+1 281-883-5500- Is this information wrong?
Summary
- Dr. Thanh Cheng is an emergency medicine physician in Humble, TX and is affiliated with SE Texas ER & Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 26 years in emergency medicine. He is also a principal investigator in FDA-approved mesenchymal stem-cell clinical trials for various diseases at Hope Biosciences.
Education & Training
- West Virginia UniversityResidency, Emergency Medicine, 1995 - 1998
- Vanderbilt University School of MedicineClass of 1995
Certifications & Licensure
- TX State Medical License 1998 - 2025
- FL State Medical License 2002 - 2005
- CA State Medical License 2001 - 2003
- WV State Medical License 1998 - 2000
- American Board of Emergency Medicine Emergency Medicine
Clinical Trials
- A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19. Start of enrollment: 2020 May 14
- A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19 Start of enrollment: 2020 Apr 20
- Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome Start of enrollment: 2022 Jan 06
- Join now to see all
Publications & Presentations
PubMed
- Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program.Ridhima Vij, Hosu Kim, Hyeonggeun Park, Djamchid Lotfi, Donna Chang, Cheng, T. C., Thanh Cheng> ;Stem Cell Research & Therapy. 2023 Oct 5
- 1 citationsFrequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report.Ridhima Vij, Mallika Tripathy, Hosu Kim, Hyeonggeun Park, Djamchid Lotfi, Donna Chang, Cheng, T. C., Thanh Cheng> ;Journal of Translational Autoimmunity. 2022 Jan 1
- 15 citationsPrehospital identification of acute coronary ischemia using a troponin T rapid assay.Jonathan Newman, Neal Aulick, Thanh Cheng, Steven Faynor, Robert Curtis, Don Mercer, Janet M. Williams, Gerald R. Hobbs> ;Prehospital Emergency Care. 1999 Apr 1
Hospital Affiliations
- SE Texas ER & HospitalHumble, Texas
External Links
- Linked inhttp://www.linkedin.com/in/thanh-c-61400619
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: